Verastem shares jump 20% after positive cancer drug trial update
Verastem Oncology shares rose 20% Thursday, their best day since November 2025, after a positive update on experimental drug VS-7375 in second-line metastatic pancreatic ductal adenocarcinoma. Analysts also lifted price targets.